NIKI BIOSOLUTIONS INC
NIKI · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $3.22
- Today’s Low
- $2.62
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.84
- Previous Close
- $3.02
- Volume
- 16.21K
- Market Cap
- $9.41M
- P/E Ratio
- --
- EPS
- $-3.53
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 116 VILLAGE BOULEVARD, PRINCETON, NJ, UNITED STATES, 08540
- Country
- GB
- Listing Date
- 2018-12-18
- Fiscal Year End
- December
- Shares Outstanding
- 3.61M
- CIK
- 0001734005
- Website
- www.aptorumgroup.com
Niki BioSolutions, Inc., is a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
Financial Metrics
Revenue
2025-12-31
$0
2025-09-30
$0
2024-12-31
$0
2024-09-30
--
Operating Expenses
2025-12-31
$825.13K
2025-09-30
$589.63K
2024-12-31
-$558.59K
2024-09-30
$2.46M
Net Income
2025-12-31
-$307.49K
2025-09-30
-$613.99K
2024-12-31
-$919.9K
2024-09-30
-$2.64M
Net Profit Margin
2025-12-31
--
2025-09-30
--
2024-12-31
--
2024-09-30
--
Earnings Per Share
2025-12-31
$-0.37
2025-09-30
$-0.85
2024-12-31
--
2024-09-30
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2025-12-31
-$825.13K
2025-09-30
-$589.63K
2024-12-31
$275.92K
2024-09-30
-$2.33M
Effective Tax Rate
2025-12-31
--
2025-09-30
--
2024-12-31
--
2024-09-30
--
| Item | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -- |
| Operating Expenses | $825.13K | $589.63K | -$558.59K | $2.46M |
| Net Income | -$307.49K | -$613.99K | -$919.9K | -$2.64M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.37 | $-0.85 | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$825.13K | -$589.63K | $275.92K | -$2.33M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.